2010, Number 2
<< Back Next >>
Arch Med Actual Trac Gen Inf 2010; 2 (2)
Impacto y Prevalencia de los Factores de Riesgo en Cancer Cervicouterino (Ca Cu)
Briseño HH
Language: Spanish
References: 11
Page: 5-9
PDF size: 41.97 Kb.
ABSTRACT
Background: In the female population, cervical cancer is the leading cause of death from malignant neoplasms, particularly in the 25 to 64 years of age.
Materials and Methods: Retrospective study of 96 patients with cervical cancer, 55 (57.29%) in situ and 41 (42.71%) invasive, evaluated the risk factors and their impact on the incidence of CA CU. Using the X2 test for statistical analysis.
Results: The peak incidence for CA CU site was 35 to 39 years and invasive at 65 years and over. The younger age of onset of sexual life were 10 to 19 years in 38 (92.7%) of 41 women against invasive AC 43 (78%) of 55 women of CA in situ, with p = 0.04. The absence in taking Pap was more marked in the group with invasive CA 23 (56%) of 41 patients versus 14 (25.4%) of 55 in situ, with p = 0.004. The level of literacy and primary education in the CA group was invasive in 36 (87.8%) of 41 cases compared with 34 (35.4%) of 55 CA CU spot, with p = 0.004.
Conclusions: Redesigning and improving screening programs have an impact on vulnerable groups, remains the critical point of health policies in the prevention of CA CU.
REFERENCES
Modificación a la NOM-014-SSA2-1994, para la prevención, detección, diagnóstico, tratamiento, control y vigilancia epidemiológica del cáncer cérvico uterino. Diario oficial de la federación 31 de mayo de 2007.
Lascano-Ponce EC, MC y Col. Factores de riesgo reproductivo y cáncer cervicouterino en la ciudad de México, Salud Pública Mex 1993; 35 (1): 65-73.
Murillo R, Molano M, Martínez G, Gamboa. HPV prevalence in Colombian women with cervical cancer: implications for vaccination in a developing country. Infect Dis Obstet Gynecol. 2009; 2009:653598. Dec 20.
Gariglio P, Gutiérrez J, Cortés E, Vázquez J. The role of retinoid deficiency and estrogens as cofactors in cervical cancer. Arch Med Res 2009; 40 (6): 449-65.
Wong LP, Wong YL, Low WY, Khoo EM, Shuib R. Cervical cancer screening attitudes and beliefs of Malaysian women who have never had a pap smear: a qualitative study. Int J Behav Med 2008; 15 (4): 289-92.
Howell LP, Gurusinghe S, Tabnak F, Sciortino S. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing. Cancer Detect Prev 2009; 32 (5-6): 372-9.
Igidbashian S. Maggioni A. et al. Sentinel Pap smears in 261 invasive cervical cancer patients in Italy. 2009; 27 Suppl 1A: 34-8.
Franceschi S, Plummer M, Clifford G, de Sanjose S, Bosch X, Herrero R, Muñoz N, Vaccarella S. Differences in the risk of cervical cancer and human papillomavirus infection by education level. Br J Cancer 2009; 101 (5): 865-70.
Head SK, Crosby RA, Moore GR. Pap smear knowledge among young women following the introduction of the HPV vaccine. J Pediatr Adolesc Gynecol 2009; 22 (4): 251-6.
Moreira ED Jr, Oliveira BG, Ferraz FM, Costa S, Costa Filho JO, Karic G. Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil: implications for health education and prevention. Int J Gynecol Cancer 2006; 16 (2): 599-603.
Hernández-Hernández DM, Linaldi-Yépez F, Apresa-García T, Escudero-de los Ríos P. Associated factors for women's non-compliance for cervical cancer screening. Rev Med Inst Mex Seguro Soc 2007; 45 (4): 313-20.